CD Formulation Expands Its Service Portfolio for Drug Delivery Research

As a reliable service provider in pharmaceutical formulation development, CD Formulation constantly expands its service range and today announces to offer a comprehensive portfolio of services for drug delivery system (DDS) research, including microneedle technology services, oral thin films technology services, microencapsulation technology services, liposome drug delivery technology services, cationic liposome technology services, lipid-based nanoparticles technology services for drug delivery systems, microparticle depots design and development services, microsphere technology development services, multiparticulate system formulation development services, and polymer nanoparticles for drug delivery services. The top priority for drug delivery research is to develop novel materials or carrier systems to achieve more effective therapeutic delivery of drugs. Conventionally, there are various drug delivery dosage forms, such as pills, capsules, tablets, solutions, suppositories, suspensions, injectables, etc. “Enhanced therapeutic effects are often accompanied by a more steady, controlled, and targeted drug delivery. With the advance of modern medicine, now a wide range of innovative drug delivery systems have been developed and applied, such as oral controlled release systems, fast dispersing dosage forms, taste-masking systems, and site-specific delivery systems,” said the Marketing Chief of CD Formulation. Currently, CD Formulation is capable of conducting the following drug delivery services for pharmaceutical companies: Microneedle Technology ServicesrnMicroneedle process development technology can ensure effective delivery of drugs to the medicinal site. The length, size, and shape of the microneedles can be individualized according to the needs of the treatment. Oral Thin Films Technology ServicesrnOral thin films avoid exposing the drug to the harsh conditions of the stomach and allows this drug delivery system to deliver a greater percentage of the active compound per dose. Hence, oral thin film technology enables rapid release of the active substance in the form of a single or multi-layer system. Microencapsulation Technology ServicesrnMicroencapsulation technology improves and enhances the appearance of substances and their properties, stores microscopic substances, delays and controls release, and protects the core material from the environment. Liposome Drug Delivery Technology ServicesrnLiposome-encapsulated drugs can significantly reduce toxicity and side effects. CD Formulation’s liposome technology provides solutions to enable pharmaceutical companies to deliver a wide range of drug molecules. Cationic Liposome Technology ServicesrnBased on the development of liposome technology, CD Formulation has been developing cationic liposome technology to improve the drug loading capacity of liposomes, which can be used to effectively load negatively charged drugs, such as nucleic acid drugs. Lipid-Based Nanoparticles Technology Services for Drug Delivery SystemsrnCD Formulation has extensive experience in conducting liposome drug delivery system technology services, liposome formulation development services, and modified liposome technology services. Microparticle Depots Design and Development ServicesrnCD Formulation can perform microparticle formulation development by adjusting polymer selection, particle size, and drug loading volume. Microsphere Technology Development ServicesrnBetter drug delivery can be realized by developing microsphere technology and microsphere preparation processes. Multiparticulate System Formulation Development ServicesrnMultiparticulate system formulations are better distributed and less likely to cause local sensitization. Polymer Nanoparticles for Drug Delivery ServicesrnPolymer nanoparticles used in drug delivery can achieve slow or controlled release through diffusion or degradation of the polymer itself. Please visit the website: https://www.formulationbio.com/ to learn more.